InfuSystem Holdings (INFU) Liabilities and Shareholders Equity (2010 - 2026)

InfuSystem Holdings has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $98.7 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 5.39% year-over-year to $98.7 million; the trailing twelve-month figure through Mar 2026 stood at $398.9 million (down 5.4% YoY), and the FY2025 full-year result was $100.6 million, down 2.95% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $98.7 million, down from $100.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $108.5 million in Q2 2024, with the low at $98.2 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $101.8 million across 5 years, with a median of $102.1 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity gained 8.44% — and 2025, when it retreated 7.07%.
• InfuSystem Holdings' Liabilities and Shareholders Equity stood at $99.4 million in 2022, then grew by 3.55% to $102.9 million in 2023, then gained by 0.68% to $103.6 million in 2024, then dropped by 2.95% to $100.6 million in 2025, then decreased by 1.89% to $98.7 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $98.7 million (Q1 2026), $100.6 million (Q4 2025), and $98.9 million (Q3 2025), per Business Quant data.